Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann-Marie Billig

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|January 10, 2018
Guidelines for Rational Cancer TherapeuticsByunghee Yoo, Ann-Marie Billig, Zdravka Medarova
Plos One|December 14, 2019
MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancerByunghee Yoo, Nikhil Meka, Patrick Sheedy, et al.
Scientific Reports|March 20, 2019
RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer ImmunotherapyByunghee Yoo, Veronica Clavijo Jordan, Patrick Sheedy, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|January 10, 2018
Guidelines for Rational Cancer TherapeuticsByunghee Yoo, Ann-Marie Billig, Zdravka Medarova
Plos One|December 14, 2019
MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancerByunghee Yoo, Nikhil Meka, Patrick Sheedy, et al.
Scientific Reports|March 20, 2019
RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer ImmunotherapyByunghee Yoo, Veronica Clavijo Jordan, Patrick Sheedy, et al.
Pageof 1